Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,19274604,V(max),"V(max) and K(m) values of MMF hydrolysis in pooled human liver microsomes were 1368 +/- 44 nmol min(-1) mg(-1) protein and 1030 +/- 65 microM, respectively.",Influence of carboxylesterase 2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. ,Vmax-Q66,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19274604/),[nM] / [mg·min],1368,121494,DB00677,Isoflurophate
,19274604,K(m),"V(max) and K(m) values of MMF hydrolysis in pooled human liver microsomes were 1368 +/- 44 nmol min(-1) mg(-1) protein and 1030 +/- 65 microM, respectively.",Influence of carboxylesterase 2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. ,Km -Q1,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19274604/),μM,1030,121495,DB00677,Isoflurophate
,19274604,IC(50),"Hydrolytic activity was inhibited by the CES inhibitors phenylmethylsulfonylfluoride, bis-p-nitorophenylphosphate and diisopropylfluorophosphate, with IC(50) values of 77.1, 3.59 and 0.0312 microM, respectively.",Influence of carboxylesterase 2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. ,IC50-Q10,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19274604/),μM,77.1,121496,DB00677,Isoflurophate
,19274604,IC(50),"Hydrolytic activity was inhibited by the CES inhibitors phenylmethylsulfonylfluoride, bis-p-nitorophenylphosphate and diisopropylfluorophosphate, with IC(50) values of 77.1, 3.59 and 0.0312 microM, respectively.",Influence of carboxylesterase 2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. ,IC50-Q10,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19274604/),μM,3.59,121497,DB00677,Isoflurophate
,19274604,IC(50),"Hydrolytic activity was inhibited by the CES inhibitors phenylmethylsulfonylfluoride, bis-p-nitorophenylphosphate and diisopropylfluorophosphate, with IC(50) values of 77.1, 3.59 and 0.0312 microM, respectively.",Influence of carboxylesterase 2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. ,IC50-Q10,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19274604/),μM,0.0312,121498,DB00677,Isoflurophate
,29667134,maximum tolerated dose,The maximum tolerated dose was 3 mg/m2/day.,"Two phase I, pharmacokinetic, and pharmacodynamic studies of DFP-10917, a novel nucleoside analog with 14-day and 7-day continuous infusion schedules. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/29667134/),[mg] / [d·m2],3,152689,DB00677,Isoflurophate
,17280881,run time,The chromatographic separation was achieved on a Waters Atlantis C18 column with a run time of 4 min.,"Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/17280881/),min,4,262144,DB00677,Isoflurophate
